At N2Jenomics Lab Pvt. Ltd., we provide comprehensive Chromatin Immunoprecipitation Sequencing (ChIP-Seq) services for high-resolution mapping of protein–DNA interactions across the genome. By combining optimized chromatin immunoprecipitation workflows with advanced Illumina next-generation sequencing, we generate high-quality datasets that help researchers investigate transcription factor binding, histone modifications, and epigenetic regulation.
Our integrated wet-lab and bioinformatics solutions enable accurate identification of regulatory elements and molecular mechanisms underlying development, disease, and gene expression.
Optimized experimental workflows, stringent quality control, and robust data processing generate reliable, publication-ready datasets suitable for high-impact research.
We provide guidance on biological replicates, appropriate controls, and experimental optimization to ensure reproducible and statistically robust results.
Our ChIP-Seq protocols are compatible with a wide range of sample types, including cultured cells, fresh or frozen tissues, clinical specimens, and multiple animal and plant species.
Our experienced bioinformatics team delivers end-to-end data analysis, including peak calling, differential binding analysis, motif discovery, genomic annotation, pathway enrichment, and publication-ready visualizations.
Whether your research focuses on transcription factors, histone modifications, chromatin organization, or epigenetic regulation, our ChIP-Seq service provides the accuracy, sensitivity, and analytical depth needed to accelerate your discoveries.
Chromatin Immunoprecipitation Sequencing (ChIP-Seq) is a powerful next-generation sequencing (NGS) technique used to identify protein–DNA interactions across the genome. By combining chromatin immunoprecipitation (ChIP) with high-throughput sequencing, ChIP-Seq precisely maps the genomic locations where transcription factors, histone modifications, and other DNA-binding proteins interact with chromatin.
Using highly specific antibodies, DNA fragments bound to the target protein are enriched, sequenced, and analyzed to generate a genome-wide binding profile. ChIP-Seq has become an essential tool for studying gene regulation, epigenetic modifications, chromatin organization, cellular differentiation, and disease mechanisms.
Compared with conventional ChIP-qPCR, ChIP-Seq provides genome-wide coverage, higher sensitivity, greater resolution, and the ability to discover novel regulatory elements.
ChIP-Seq uses target-specific antibodies to accurately identify binding sites of transcription factors, histone modifications, and other chromatin-associated proteins, providing detailed insights into gene regulatory mechanisms.
By combining chromatin immunoprecipitation with next-generation sequencing, ChIP-Seq enables comprehensive analysis of protein-binding events across the entire genome, helping uncover complex regulatory networks.
Compatible with a wide variety of biological samples, including cultured cells, tissues, clinical specimens, and multiple plant and animal species.
Compare protein-binding patterns between different biological conditions, developmental stages, treatments, or disease states to identify dynamic regulatory changes.
Optimized experimental workflows and rigorous quality control ensure highly reproducible, publication-quality datasets suitable for advanced epigenetic research.
| Feature | ChIP-Seq | ATAC-Seq |
|---|---|---|
| Primary Objective | Maps specific protein–DNA interactions | Profiles genome-wide chromatin accessibility |
| Targets | Transcription factors, histone modifications, chromatin-associated proteins | Open chromatin regions and regulatory elements |
| Antibody Requirement | Yes | No |
| Specificity | High—identifies binding sites of specific proteins | Detects accessible chromatin but not specific binding proteins |
| Sample Preparation | Antibody-based immunoprecipitation | Tn5 transposase-mediated tagmentation |
| Best Applications | Gene regulation, transcription factor binding, histone modification studies | Chromatin accessibility, enhancer discovery, regulatory landscape profiling |
| Data Interpretation | Direct identification of protein-binding sites | Often integrated with RNA-Seq or ChIP-Seq for functional interpretation |
| Service | Recommended Data Output | Sequencing Platform | Recommendations |
|---|---|---|---|
| Histone Modification ChIP-Seq | ~8 GB per sample | Illumina NovaSeq / HiSeq | At least two biological replicates per group, including matched ChIP and Input controls |
| Transcription Factor ChIP-Seq | ~6 GB per sample | Illumina NovaSeq / HiSeq | At least two biological replicates per group, including matched ChIP and Input controls |

| Analysis | Availability | Notes |
|---|---|---|
| Raw data quality assessment | Included | Quality control of sequencing data |
| Reference genome annotation | Included | Genome mapping statistics |
| Read alignment | Included | Alignment to the reference genome |
| Peak calling | Included | Identification of protein-DNA binding regions |
| GO functional annotation | Included | Functional analysis of peak-associated genes |
| KEGG pathway annotation | Included | Biological pathway analysis |
| Differential peak analysis | Available | Requires two or more sample groups |
| GO enrichment analysis | Available | Performed on differential peaks |
| KEGG enrichment analysis | Available | Performed on differential peaks |
| Motif analysis | Included | Identification of enriched DNA-binding motifs |

ChIP-Seq is widely used to investigate protein-DNA interactions and epigenetic regulation, providing valuable insights into gene expression and chromatin organization.
| Sample Type | Recommended Input | Minimum Input | Requirements |
|---|---|---|---|
| ChIP DNA | ≥10 ng | 5 ng | Concentration ≥1 ng/µl; OD260/280: 1.8–2.0; RNase-treated; high-quality DNA without degradation |
| Cell Samples | ≥2 × 10⁷ cells | 1 × 10⁵ cells | Crosslinked with 1% formaldehyde, PBS washed, snap-frozen, stored at -80°C |
| Tissue Samples | ≥500 mg | — | Freshly collected, snap-frozen in liquid nitrogen, transported on dry ice, avoid repeated freeze-thaw cycles |
We assist in selecting and validating high-quality antibodies to improve enrichment efficiency and reduce background noise.
Our scientists have expertise in ChIP-Seq for plant, animal, tissue, and cell samples, ensuring optimized workflows for diverse research projects.
Strict quality control is maintained throughout sample processing, sequencing, and data analysis to generate dependable, publication-ready datasets.
Our workflows are optimized for a wide range of sample types and input amounts, with project-specific recommendations to maximize sequencing success.
We provide complete data analysis, including peak calling, motif discovery, genomic annotation, pathway analysis, and detailed reports to support biological interpretation.
An Input sample is fragmented chromatin DNA that has not undergone immunoprecipitation. It serves as a control for background correction and improves the accuracy of peak identification.
Input samples represent total chromatin DNA, while IP samples contain DNA enriched by the target antibody. Comparing both datasets helps identify genuine protein-DNA binding sites.
For most ChIP-Seq experiments, ≥20 million clean reads per sample are recommended. Higher sequencing depth may be required depending on the target protein and study design.
PCR amplification is commonly used during library preparation. Optimized PCR cycles help minimize amplification bias while ensuring sufficient library yield.
DNA fragments between 200–300 bp are generally recommended for optimal library quality and sequencing performance.
Yes. An Input DNA control is typically included to reduce background signals and improve the reliability of peak calling.
Data quality depends on antibody specificity, chromatin preparation, fragmentation efficiency, sequencing depth, and bioinformatics analysis.
Both sonication and enzymatic digestion are widely used. The preferred method depends on the sample type, target protein, and experimental objectives.
False positives may result from poor sample quality, PCR bias, repetitive genomic regions, or sequencing artifacts. Proper controls and quality filtering help minimize these effects.
ChIP-Seq is compatible with most organisms that have a well-assembled reference genome and reliable genome annotation. Please contact our team to discuss species-specific requirements.